Position Description
Job Title: Senior Manager, Vaccine Translational Research
Location: Nairobi, Kenya
Reports to: Director Global Partnerships, Antibody Discovery and Development, NAC
POSITION SUMMARY:
Help IAVI translate our scientific discovery into global health impact!
IAVI is seeking a Senior Manager, Vaccine Translational Research who will be support, manage, and execute the translational research activities in the ADVANCE program leading workplan development for research activities. The Senior Manager will collaborate directly with ADVANCE strategic area leads, researchers, program managers, operations team, and other key stakeholders across the IAVI-ADVANCE Clinical Research Center (CRC) network in East and Southern Africa. The Senior Manager will design programming to promote innovation, sustainable research platforms, technical rigor, and collaboration within the ADVANCE research community, creating equitable opportunities for diverse stakeholders at all levels to partner in the design of an HIV vaccine. The Senior Manager will align the translational research agenda, implementation activities, and learning platforms to a defined framework ensuring successful delivery of translational science activities, while assisting and advising stakeholders on technical and programmatic matters.
KEY RESPONSIBILITIES:
Scientific leadership for the ADVANCE program
Manage key scientific partnerships in Africa to support IAVI’s mission
Programmatic support ensuring successful execution of scientific program
Lead scientific capacity strengthening of the ADVANCE CRC network
EDUCATION AND WORK EXPERIENCE:
QUALIFICATIONS AND SKILLS:
Organizational Overview:
IAVI is a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges including HIV and tuberculosis. Our mission is to translate scientific discoveries into affordable, globally accessible public health solutions. Through scientific and clinical research in Africa, India, Europe, and the U.S., IAVI is pioneering the development of biomedical innovations designed for broad global access. We develop vaccines and antibodies in and for the developing world and seek to accelerate their introduction in low-income countries. IAVI programs and partnerships are grounded in the regions of the world where the disease burden is the greatest, and our approach emphasizes sustainability. Our network of clinical research center partners in Africa and India helps strengthen in-country research capacity and supports the training and education of the next generation of scientists. The global impact of our science includes fundamental contributions to understanding the biology of HIV infection, which IAVI and others are applying toward advancing vaccine science and immunology. IAVI accelerates scientific discovery and development by fostering unique collaborations among academia, industry, local communities, governments, and funders to explore new and better ways to address public health threats that disproportionately affect people living in poverty. Our global reach, including a clinical research network in five countries in sub-Saharan Africa and in India, has allowed us to make fundamental contributions to understanding the epidemiology, transmission, virology, and immunology of HIV. This work played a key role in facilitating the design of promising HIV vaccine candidates, as well as the discovery of broadly neutralizing antibodies that are now being advanced as promising approaches for HIV prevention. Our integrated capabilities in vaccine and antibody discovery, development, and clinical research take advantage of bio-pharmaceutical industry expertise to accelerate the development and testing of prevention methods for HIV and other diseases. Through the Product Development Center, we support external researchers with technical and scientific expertise to accelerate the development of their own products.
About ADVANCE:
ADVANCE (Accelerate the Development of Vaccines and New Technologies to Combat the AIDS Epidemic) is a ten-year cooperative agreement with the U.S. Agency for International Development (USAID), through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). This visionary $200 million program will run until June 2026 and is part of IAVI’s 22-year collaboration with USAID that has significantly impacted the field of HIV vaccine R&D and accelerated the search for innovative prevention tools, including a safe and globally effective HIV vaccine. USAID’s long-term investment and willingness to foster advances in science to benefit the world’s most at-risk populations have enabled IAVI’s unique model in Africa and India.
IAVI CORE VALUES:
Disclaimer: Nothing in this job description restricts management's right to assign or reassign duties and responsibilities to this job at any time. The above statements are intended to describe the general nature and level of work being performed by individuals assigned to this position. They are not intended to be an exhaustive list of all duties, responsibilities and skills required of personnel so classified. This document does not create an employment contract, implied or otherwise, other than an “at-will” relationship. IAVI is an equal opportunity employer and applicants will be considered for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.
IAVI IS AN EQUAL OPPORTUNITY EMPLOYER actively committed to fostering a diverse and inclusive global organization. IAVI believes that diversity and inclusion among our teammates is critical, and we seek to recruit, develop and retain the most talented people from a representative candidate pool. At IAVI, we celebrate the spectrum of colleagues’ experiences and believe that dedication to our mission above all is essential to our success as a scientific global non-profit. IAVI upholds these principles through IAVI’s Global Diversity and Inclusion Committee.
IAVI has zero tolerance for discrimination or harassment on the basis of race, color, ethnicity, caste, national origin, home language, ancestry, religion, marital or civil partnership status, age, physical or mental disability, HIV status and any other medical condition, genetic information, pregnancy, sexual orientation, gender identity or expression, and veteran status, in addition to any other status protected under the law in any of our locations worldwide.